Myriad Genetics, Inc.
Cancer biomarkers
Last updated:
Abstract:
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
Status:
Grant
Type:
Utility
Filling date:
13 Mar 2018
Issue date:
10 Dec 2019